Inventor · disambiguated record
Wenying Chai
Also filed as: CHAI WENYING
31 granted patents·16 pending applications·128 citations·filing 2000–2023
96Inventor score
Files withJANSSEN PHARMACEUTICA NV28ORTHO MCNEIL PHARM INC4CARRUTHERS NICHOLAS I3CHAI WENYING3HUTCHISON MEDIPHARMA LTD2
Top patents by PatentIndex Score
47 records- 0194US11667644B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jun 6, 2023·2 cites·31 claims
- 0293US11827638B2Imidazopyrrolopyridine as inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Nov 28, 2023·2 cites·3 claims
- 0392US9079911B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jul 14, 2015·13 cites·17 claims
- 0492US8653263B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsCHAI WENYING·Filed 2010·Granted Feb 18, 2014·24 cites·30 claims
- 0591US10981911B2Imidazopyrrolopyridine as inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 20, 2021·6 cites·2 claims
- 0689US10947252B2Inhibitors of KEAP1-Nrf2 protein-protein interactionJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Mar 16, 2021·3 cites·1 claims
- 0789US6803362B2Heterocyclic compoundsORTHO MCNEIL PHARM INC·Filed 2002·Granted Oct 12, 2004·38 cites·37 claims
- 0888US12378254B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Aug 5, 2025·0 cites·13 claims
- 0987US11254673B2Small molecule inhibitors of NF-κB inducing kinaseJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 22, 2022·2 cites·13 claims
- 1087US11059828B2Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 13, 2021·3 cites·21 claims
- 1185USRE48841EDisubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Dec 7, 2021·2 cites·37 claims
- 1282US9265770B21,2,5-substituted benzimidazoles as FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 23, 2016·3 cites·11 claims
- 1381US8952177B21,2,6-substituted benzimidazoles as FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 10, 2015·4 cites·9 claims
- 1480US9067917B21,2,5-substituted benzimidazoles as FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 30, 2015·3 cites·9 claims
- 1579US9089569B21,2,6-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 28, 2015·3 cites·13 claims
- 1675US8642583B2Serotonin receptor modulatorsCARRUTHERS NICHOLAS I·Filed 2009·Granted Feb 4, 2014·2 cites·21 claims
- 1774US11427601B1Inhibitors of KEAP1-Nrf2 protein-protein interactionJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Aug 30, 2022·0 cites·44 claims
- 1873US8183239B2Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptorBONAVENTURE PASCAL·Filed 2006·Granted May 22, 2012·2 cites·35 claims
- 1971US7402680B2Fused heterocyclic compoundsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Jul 22, 2008·4 cites·21 claims
- 2071US6288235B1Methods for the synthesis of highly substituted 2,4-dioxopiperidine librariesORTHO MCNEIL PHARM INC·Filed 2000·Granted Sep 11, 2001·2 cites·10 claims
- 2168US7897771B2Fused heterocyclic compoundsJANSSEN PHARMACEUTICA NV·Filed 2009·Granted Mar 1, 2011·0 cites·2 claims
- 2267US11897900B2Inhibitors of KEAP1-Nrf2 protein-protein interactionJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 13, 2024·0 cites·17 claims
- 2366US6638967B2Thiophene of furan pyrrolidine compoundsORTHO MCNEIL PHAMRACEUTICAL IN·Filed 2001·Granted Oct 28, 2003·8 cites·7 claims
- 2465US7317025B2Non-peptidic NPY Y2 receptor inhibitorsJOHNSON & JOHNSON PHARM RES·Filed 2004·Granted Jan 8, 2008·2 cites·10 claims
- 2563US2017129901A1Disubstituted Octahydropyrrolo[3,4-C]Pyrroles As Orexin Receptor ModulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 2662US2025282785A1Pyrrolidinone derivatives as inhibitors of nf kappa b inducing kinaseJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 2761US9682971B21,2,5-Substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 20, 2017·0 cites·13 claims
- 2861US2025304567A1Pyrrolidione derivatives as inhibitors of nf kappa b inducing kinaseJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 2961US2025282768A1Pyrrolidinone derivatives as inhibitors of nf kappa b inducing kinaseJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 3059US9695149B21,2,6-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 4, 2017·0 cites·20 claims
- 3158US2015335651A1DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORSJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
- 3255US2024158392A1Small molecule inhibitors of salt inducible kinasesJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 3354US2014038943A1Serotonin receptor modulatorJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
- 3454US2024174662A1Small molecule inhibitors of salt inducible kinasesJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 3554US2008132540A1Non-peptidic npy y2 receptor inhibitorsCARRUTHERS NICHOLAS I·Filed 2007·Application pending·0 cites
- 3652US9682972B21,2,5-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jun 20, 2017·0 cites·12 claims
- 3752US2011040088A1Fused heterocyclic compoundsCARRUTHERS NICHOLAS I·Filed 2010·Application pending·0 cites
- 3852US2005085487A1Heterocyclic compoundsFiled 2004·Application pending·0 cites
- 3951US9981909B2Serotonin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted May 29, 2018·0 cites·16 claims
- 4050US10172856B22,4-diaminopyrimidine derivatives as histamine H4 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jan 8, 2019·0 cites·22 claims
- 4150US2015291593A1Novel heteroaryl and heterocycle compounds, compositions and methodsHUTCHISON MEDIPHARMA LTD·Filed 2013·Application pending·0 cites
- 4249US2015307520A1Novel heteroaryl and heterocycle compounds, compositions and methods thereofHUTCHISON MEDIPHARMA LTD·Filed 2013·Application pending·0 cites
- 4347US6686503B2Methods for the synthesis of highly substituted 2,4-dioxopiperidine librariesORTHO MCNEIL PHARM INC·Filed 2001·Granted Feb 3, 2004·0 cites·12 claims
- 4447US2012129870A1Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptorCHAI WENYING·Filed 2008·Application pending·0 cites
- 4547US2012015957A1Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptorCHAI WENYING·Filed 2008·Application pending·0 cites
- 4642US6872834B2Phenyl-substituted indoles and indazolesORTHO MCNEIL PHARM INC·Filed 2001·Granted Mar 29, 2005·0 cites·12 claims
- 4735US2001051632A1Phenyl-substituted indolizines and tetrahydroindolizinesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wenying Chai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →